12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Deals

Inovio, PATH deal

Inovio and PATH's Malaria Vaccine Initiative (MVI) expanded a 2010 deal and will conduct a Phase I/IIa trial of Inovio's SynCon DNA malaria vaccine delivered via electroporation. The...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >